Results 281 to 290 of about 138,331 (318)

Glucose‐Dependent Insulinotropic Polypeptide and Glucagon After Weight Loss Induced by Diet or Bariatric Surgery

open access: yesObesity, Volume 33, Issue 12, Page 2277-2288, December 2025.
ABSTRACT Objective This study compared the effects of a very low‐energy diet (VLED), alone or combined with sleeve gastrectomy (SG) or Roux‐en‐Y gastric bypass (RYGB), on glucose‐dependent insulinotropic polypeptide (GIP) and glucagon concentrations, hormones likely to play a role in weight loss maintenance.
Amanda Finn   +4 more
wiley   +1 more source

Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice

open access: yesObesity, Volume 33, Issue 12, Page 2296-2303, December 2025.
ABSTRACT Objective This study aimed to characterize the reasons for treatment discontinuation with injectable semaglutide or tirzepatide for obesity in regular clinical practice. Methods This cross‐sectional study used electronic health record data between January 2022 and December 2024 from a single integrated health system in Ohio and Florida.
Hamlet Gasoyan   +9 more
wiley   +1 more source

The Effect of Bariatric Surgery on Hypertension Outcomes: A Retrospective Cohort Study. [PDF]

open access: yesJ Hum Hypertens
Passman JE   +6 more
europepmc   +1 more source

Patients' perceptions of bariatric surgery in the Deep South: the impact of health literacy. [PDF]

open access: yesSurg Endosc
Harsono AAH   +9 more
europepmc   +1 more source

Development and validation of Baritrip: a multidisciplinary educational mobile application for bariatric surgery patients. [PDF]

open access: yesEinstein (Sao Paulo)
Gonçalves BC   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy